Growth Metrics

Canton Strategic Holdings (CNTN) Non Operating Income (2021 - 2026)

Canton Strategic Holdings posted quarterly Non Operating Income of -$14.7 million for Q1 2026, down 296074.34% year-on-year from N/an in Q1 2025, and up 33.17% on a QoQ basis from -$22.0 million in Q4 2025.

Canton Strategic Holdings (CNTN) has 6 years of Non Operating Income data on file, last reported at -$14.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 296074.34% year-over-year to -$14.7 million; the trailing twelve-month figure through Mar 2026 stood at -$36.7 million (down 24565.74% YoY), and the FY2025 full-year result was -$22.0 million, down 9412.05% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$14.7 million, up from -$22.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $91194.0 in Q1 2024 and bottomed at -$22.0 million in Q4 2025.
  • The 5-year median for Non Operating Income is $25532.5 (2023), against an average of -$2.7 million.
  • The widest annual swing landed in 2024, when Non Operating Income soared 249.27%; it then slumped 296074.34% in 2026.
  • A 5-year view of Non Operating Income shows it stood at -$1.6 million in 2022, then surged by 103.61% to $57379.0 in 2023, then plunged by 53.09% to $26914.0 in 2024, then slumped by 81804.72% to -$22.0 million in 2025, then surged by 33.17% to -$14.7 million in 2026.
  • The last three Non Operating Income figures came in at -$14.7 million (Q1 2026), -$22.0 million (Q4 2025), and -$8260.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 444,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 201.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -46.98 Mn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn - -14.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14.70 Mn
Dec 31, 2025 -21.99 Mn
Sep 30, 2025 -8,260.00
Jun 30, 2025 -3,993.00
Mar 31, 2025 4,965.00
Dec 31, 2024 26,914.00
Sep 30, 2024 69,719.00
Jun 30, 2024 48,397.00
Mar 31, 2024 91,194.00
Dec 31, 2023 57,379.00
Sep 30, 2023 24,955.00
Jun 30, 2023 27,682.00
Mar 31, 2023 26,110.00
Mar 31, 2022 -1.59 Mn
Dec 31, 2021 2.55 Mn
Sep 30, 2021 -312,323.00
Jun 30, 2021 -458,371.00
Mar 31, 2021 -782,463.00